Özlem Göksel
A5088984923- Asthma and respiratory diseases
- Allergic Rhinitis and Sensitization
- Drug-Induced Adverse Reactions
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Advanced Chemical Sensor Technologies
- Occupational exposure and asthma
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Contact Dermatitis and Allergies
- Indoor Air Quality and Microbial Exposure
- Air Quality and Health Impacts
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pharmaceutical studies and practices
- Pharmacovigilance and Adverse Drug Reactions
- Urticaria and Related Conditions
- Metabolomics and Mass Spectrometry Studies
- Food Allergy and Anaphylaxis Research
- Gas Sensing Nanomaterials and Sensors
- Airway Management and Intubation Techniques
- Salivary Gland Disorders and Functions
- Dermatology and Skin Diseases
- Air Quality Monitoring and Forecasting
- Occupational and environmental lung diseases
- Inflammatory mediators and NSAID effects
- Pediatric health and respiratory diseases
Ege University
2016-2025
ENT and Allergy
2024
Tarsus University
2024
Dokuz Eylül University
2024
Izmir Institute of Technology
2024
Ege Üniversitesi Tıp Fakültesi Hastanesi
2016-2024
Acıbadem Adana Hospital
2021
University of Michigan
2021
Chest Diseases Hospital
2015
Izmir Atatürk Eğitim ve Araştırma Hastanesi
2013
Pollen allergy poses a significant health and economic burden in Europe. Disease patterns are relatively homogeneous within Central Northern European countries. However, no study broadly assessed the features of seasonal allergic rhinitis (SAR) across different Southern countries with standardized approach.
Taxanes can cause hypersensitivity reactions (HSRs), which pose a significant challenge in the treatment of malignancies. Patients who are eligible for rapid drug desensitization (RDD) continue treatment; however, some patients experience breakthrough (BTRs). Data about risk factors BTRs during RDDs with HSRs to taxanes limited.
Background: Hypersensitivity to contrast media (CMs) may be common and serious. Aim: To evaluate the prevalence of CM hypersensitivity, risk factors associated with it role skin testing in its diagnosis. Methods: A structured questionnaire was administered patients who underwent computed tomography during a 1-year period. Skin tests CMs, including prick (SPTs), intradermal (IDTs) patch (PTs), were conducted on reactors (n = 24). Volunteers tolerated exposure or had never been exposed any CMs...
Abstract Background Pollen food allergy syndrome (PFAS) is a frequently underdiagnosed disease due to diverse triggers, clinical presentations, and test results. This especially relevant in geographic areas with broad spectrum of pollen sensitization, such as Southern Europe. Objectives To elucidate similarities differences PFAS nine European centers identify associated characteristics unique markers PFAS. Methods As part the @IT.2020 Multicenter Study, 815 patients seasonal allergic...
Abstract Background and Objective The updated World Health Organization (WHO) air quality guideline recommends an annual mean concentration of fine particulate matter (PM2.5) not exceeding 5 or 15 μg/m 3 in the short‐term (24 h) for no more than 3–4 days annually. However, 90% global population is currently exposed to daily concentrations surpassing these limits, especially during extreme weather conditions due transboundary dust transport influenced by climate change. Herein, effect...
Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in management remain limited. This registry-based study evaluated use montelukast adult patients, examining demographic disease characteristics, control status, phenotypes, presence atopy, regimens. Among 2053 patients analyzed, 61.76% (n = 1268; mean age: 46.2 ± 14.3 years), predominantly females (~76%), received...
Abstract Background Asthma is one of the most common causes chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence asthma asthma‐related death. Objective In this study, we aimed to determine levels asthmatic patients according national database investigate effects social markers on disease control in our region. Methods This an analysis data from 2053 adult multicentre chart study Turkey. Socioeconomic (SES) were collected questionnaires form was...
Objective The obese-asthma phenotype has gradually increased in the last few years. We aimed to assess differences between obese and non-obese patients with asthma.
Considerable overlaps exist between asthma phenotypes and the clinical significance of these remains undetermined. The objective this study is to analyze characteristics overlap using data from Turkish Adult Asthma Registry (TAAR). This cross-sectional registry included 2053 adult patients (74.8% female) with asthma. Overall, 39.3% (n = 697) had allergic-eosinophilic (AE), 26.0% 461) allergic-non-eosinophilic (ANE), 21.3% 377) non-allergic-eosinophilic (NAE), 13.4% 237)...
Abstract Objectives It is aimed to assess how physicians use chest imaging in asthma and the relationship between pathological findings related disease characteristics radiological of asthmatic patients. Background The daily practice its contribution management are not well defined. common investigate pathologies that cause respiratory symptoms evaluate differential diagnoses In this study, as a subanalysis Turkish Adult Asthma Registry, outcomes patients were examined. Methods Between March...
The adequate definition of pollen seasons is essential to facilitate a correct diagnosis, treatment choice, and outcome assessment in patients with seasonal allergic rhinitis. A position paper by the European Academy Allergy Clinical Immunology (EAACI) proposed season definitions for Northern Middle Europe.To test EAACI six Mediterranean cities seven taxa.As part @IT.2020 multi-center study, counts Poaceae, Oleaceae, Fagales, Cupressaceae, Urticaceae (Parietaria spp.), Compositae (Ambrosia...
An objective of the Severe Heterogeneous Asthma Registry, Patient-centered (SHARP) is to produce real-world evidence on a pan-European scale by linking nonstandardised, patient-level registry data. Mepolizumab has shown clinical efficacy in randomised controlled trials and prospective studies could therefore serve as proof principle for this novel approach. The aim present study was harmonise data from 10 national severe asthma registries characterise patients receiving mepolizumab, assess...
National data on asthma characteristics and the factors associated with uncontrolled seem to be necessary for every country. For this purpose, we developed Turkish Adult Asthma Registry patients aiming take a snapshot of our patients, thereby assigning unmet needs niche areas intervention.Case entries were performed between March 2018 2022. A web-based application was used record data. Study outcomes demographic features, disease characteristics, control levels, phenotypes.The registry...
<b><i>Background:</i></b> Omalizumab has demonstrated therapeutic benefits both in controlled clinical trials and real-life studies. However, research concerning the long-term effects tolerability of omalizumab is needed. The main objective this study was to evaluate effectiveness treatment with for up 5 years. <b><i>Methods:</i></b> A multicenter, retrospective, chart-based carried out compare documented exacerbations, hospitalizations,...
Characteristics of asthma in the elderly population is not well-known. The aim present study was to evaluateasthma population, compare disease characteristics between patients diagnosed <60 (aged asthma) and ≥60 (elderlyasthma) years age.Materials methods: a prospective, multicenter, cross-sectional type. A questionnaire filled out 60years age over, that have been followed for at least 3 months. Asthma Control Test (ACT), eight-item MoriskyMedication Adherence Scale (MMAS-8) out, inhaler...